Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Swedish Match in the acquisition of Gotlandssnus
Mandate

Vinge advises Swedish Match in the acquisition of Gotlandssnus

July 31, 2018 M&A

Founded in 2002, Gotlandssnus develops, produces, and sells both snus and nicotine-free products, with sales in Sweden, the US, Asia, and parts of Europe.

The company sells popular brands such as Jakobsson’s snus and Qvitt (nicotine and tobacco free pouches). Gotlandssnus produces approximately 4 million cans per year. The production facility and head office are located in Romakloster, Gotland. The current managing director and founder Henrik Jakobsson will remain as the managing director of Gotlandssnus and also as a minority shareholder of the company.
 
Vinge’s team consisted of partner Jonas Johansson and associate Karl Klackenberg.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026